_CCMBM 3_2016.qxp_- 23/01/17 09:39 Pagina 169
From the Editor-in-Chief his last for 2016 is closing the 13th year of activity of Clinical Cases in Mi-
T
neral and Bone Metabolism (CCMBM) and we are very proud of this success. The Journal is internationally recognized and its popularity is increasing,
with an even brighter future as the Impact Factor will be obtained. This number of CCMBM is presenting a unique collection of reports in the area of
orthopaedics and metabolic bone diseases. Two papers dedicated to nutrition and bone are facing the area of microelements for bone boost and of natural mineral waters to increase intestinal calcium absorption. Hanan Saaddedin Abushwereb et al. reported on the screening and management of osteoporosis in breast cancer women treated with aromatase inhibitors. The role of vitamin D receptor gene polymorphism and the incidence of osteoporosis is evaluated by Raheleh Dabirnia et al. in Iranian women. Carlo Doria et al. are reporting on a prospective randomized trial on the role of denosumab in the treatment of osteoporosis in prostate carcinoma patients. In another clinical study Gianfilippo Caggiari et al. describe the safety and efficacy of teriparatide vs alendronate in postmenopausal women. Denise van de Laarschot et al. is offering an overview on the role of bisphosphonates in inducing atypical femoral fractures. Two papers treat the problem of acetabular fractures and their treatment. The role of stem cells and biomaterials in repairing bone defects is described in two papers by Roberto Bertolai et al. and Iacopo Castellini et al. The problem of vertebroblasty to cure osteoporotic fractures is introduced by Paolo Tranquilli Leali et al. Marco Pellegrino et al. covered the use of Steadman microfracture technique to cure the chondral injuries of the knee. Finally, eight case reports describe: the use of neridronate and denosumab in pregnancy-associated osteoporosis, malabsorption segregating with chondrocalcinosis, craniofacial fibrous dysplasia and its treatment with denosumab, simvastatin-induced rhabdomyolysis, diabetes in primary hyperparathyroidism, and femoral fracture in Fahr’s syndrome. As always CCMBM takes only responsibility for the editorial content and peer-review. CCMBM is capitalizing the excitement and interest of its readers towards the Journal contents. I am confident that the Journal will continue to grow reaching an increasing audience of physicians with an interest in bone health. Maria Luisa Brandi, M.D., Ph.D.
Clinical Cases in Mineral and Bone Metabolism 2016; 13(3):169
169
From the Editor-in-Chief his last for 2016 is closing the 13th year of activity of Clinical Cases in Mi-
T
neral and Bone Metabolism (CCMBM) and we are very proud of this success. The Journal is internationally recognized and its popularity is increasing,
with an even brighter future as the Impact Factor will be obtained. This number of CCMBM is presenting a unique collection of reports in the area of
orthopaedics and metabolic bone diseases. Two papers dedicated to nutrition and bone are facing the area of microelements for bone boost and of natural mineral waters to increase intestinal calcium absorption. Hanan Saaddedin Abushwereb et al. reported on the screening and management of osteoporosis in breast cancer women treated with aromatase inhibitors. The role of vitamin D receptor gene polymorphism and the incidence of osteoporosis is evaluated by Raheleh Dabirnia et al. in Iranian women. Carlo Doria et al. are reporting on a prospective randomized trial on the role of denosumab in the treatment of osteoporosis in prostate carcinoma patients. In another clinical study Gianfilippo Caggiari et al. describe the safety and efficacy of teriparatide vs alendronate in postmenopausal women. Denise van de Laarschot et al. is offering an overview on the role of bisphosphonates in inducing atypical femoral fractures. Two papers treat the problem of acetabular fractures and their treatment. The role of stem cells and biomaterials in repairing bone defects is described in two papers by Roberto Bertolai et al. and Iacopo Castellini et al. The problem of vertebroblasty to cure osteoporotic fractures is introduced by Paolo Tranquilli Leali et al. Marco Pellegrino et al. covered the use of Steadman microfracture technique to cure the chondral injuries of the knee. Finally, eight case reports describe: the use of neridronate and denosumab in pregnancy-associated osteoporosis, malabsorption segregating with chondrocalcinosis, craniofacial fibrous dysplasia and its treatment with denosumab, simvastatin-induced rhabdomyolysis, diabetes in primary hyperparathyroidism, and femoral fracture in Fahr’s syndrome. As always CCMBM takes only responsibility for the editorial content and peer-review. CCMBM is capitalizing the excitement and interest of its readers towards the Journal contents. I am confident that the Journal will continue to grow reaching an increasing audience of physicians with an interest in bone health. Maria Luisa Brandi, M.D., Ph.D.
Clinical Cases in Mineral and Bone Metabolism 2016; 13(3):169
169
